Clinical Trial Update: Study of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating SHR-8068 in combination with Adebrelimab and platinum-based chemotherapy for advanced gastric adenocarcinoma and esop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma
• Gastric Adenocarcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• SHR-8068

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Advanced Gastric Adenocarcinoma and Esophageal Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING